3 Health Services Stocks On The Rise
One out of the three major indices are trading lower today with the
Dow Jones Industrial Average
(
^DJI
) trading down 56 points (-0.3%) at 17,863 as of Thursday, July 7, 2016, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,647 issues advancing vs. 1,277 declining with 139 unchanged.
The Health Services industry currently sits up 0.3% versus the S&P 500, which is unchanged. Top gainers within the industry include
(
), up 1.5%, and
(
), up 1.5%. A company within the industry that fell today was
(
), up 1.6%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
(
) is one of the companies pushing the Health Services industry higher today. As of noon trading, Hologic is up $0.69 (2.0%) to $35.39 on average volume. Thus far, 1.9 million shares of Hologic exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $34.60-$35.79 after having opened the day at $34.70 as compared to the previous trading day's close of $34.70.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. Hologic has a market cap of $9.7 billion and is part of the health care sector. Shares are down 10.3% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts who rate Hologic a buy, no analysts rate it a sell, and 7 rate it a hold.
TheStreet Ratings rates
Hologic
as a
. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, revenue growth, expanding profit margins, notable return on equity and compelling growth in net income. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $0.90 (0.9%) to $104.40 on average volume. Thus far, 916,636 shares of Edwards Lifesciences exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $103.50-$105.28 after having opened the day at $103.50 as compared to the previous trading day's close of $103.50.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Lifesciences has a market cap of $20.9 billion and is part of the health care sector. Shares are up 31.1% year-to-date as of the close of trading on Wednesday. Currently there are 12 analysts who rate Edwards Lifesciences a buy, no analysts rate it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Edwards Lifesciences
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, good cash flow from operations and growth in earnings per share. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full
Edwards Lifesciences Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $0.60 (0.8%) to $80.03 on light volume. Thus far, 804,010 shares of St Jude Medical exchanged hands as compared to its average daily volume of 4.1 million shares. The stock has ranged in price between $79.34-$80.09 after having opened the day at $79.34 as compared to the previous trading day's close of $79.43.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures, and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide. St Jude Medical has a market cap of $22.2 billion and is part of the health care sector. Shares are up 28.6% year-to-date as of the close of trading on Wednesday. Currently there are 3 analysts who rate St Jude Medical a buy, no analysts rate it a sell, and 18 rate it a hold.
TheStreet Ratings rates
St Jude Medical
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, expanding profit margins and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full
St Jude Medical Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).